X4 Pharmaceuticals Inc (NASDAQ:XFOR)
| 0.8902 BATS BZX Real-Time Price As of 2:05pm ET |  +0.005 / +0.56%Today’s Change | 0.65 Today|||52-Week Range 2.58 | -10.35% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | -10.9M | -9.4M | -10.9M | -13.4M | |
| Depreciation | 36.0K | 34.0K | 20.0K | 24.0K | ||
| Total Other Cash Flow | 1.3M | 3.1M | 639.0K | 774.0K | ||
| Funds From Operations | -9.6M | -6.2M | -10.2M | -12.6M | ||
| Funds From/For Other Operating Expenses | -1.4M | 909.0K | 1.5M | 1.7M | ||
| Net Cash Flow - Operating Activities | -8.2M | -7.1M | -11.8M | -14.3M | ||
| Investing | Capital Expenditures | -7.0K | 0.00 | -- | -10.0K | |
| Other Investing - Sources | 0.00 | 0.00 | 26.4M | 0.00 | ||
| Net Cash Flow Investing | -7.0K | 0.00 | 26.4M | -10.0K | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 9.8M | ||
| Long Term Debt Reduction | -583.0K | 1.8M | 0.00 | -2.9M | ||
| Net Proceeds Stock Sale | -43.0K | 70.0K | 113.0K | 79.7M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | -43.0K | 43.0K | 0.00 | 0.00 | ||
| Net Cash Flow - Financing | -583.0K | -2.9M | 113.0K | 86.7M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -189.0K | 23.0K | -21.0K | 19.0K | |
| Net Change In Cash | -8.8M | -10.0M | 14.8M | 72.4M | ||
